arrow
K

Katherine K. Matthay

University of California San Francisco
H指数:100
被引数:3.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

International neuroblastoma risk group consortium: a model of networking for rare cancers
2025-08-250
OAAI
ALK upregulates POSTN and WNT signaling to drive neuroblastoma
2024-03-011
OAAI
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial
2024-01-105
OA
Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma
2023-08-013
OAAI
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results
2023-04-0346
OAAI
Modulation of Radiation Biomarkers in a Randomized Phase II Study of 131I-MIBG With or Without Radiation Sensitizers for Relapsed or Refractory Neuroblastoma
2023-04-010
PRE
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting

难治性,复发性或进行性神经母细胞瘤的早期临床试验资格和反应评估标准: 美国国家癌症研究所临床试验计划会议的共识声明

CANCER
IF5.1
2022-09-135
OAAI
Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials
2017-09-2348
OAAI